| 摘要 |
The present invention relates to a dosage form for transmucosal administr ation comprising a therapeutically effective amount of aliskiren or a pharma ceutically acceptable salt thereof, and an excipient for transmucosal delive ry, wherein the active ingredient is present in an amount of 0.001 to 80% by weight based on the total weight of the dosage form.
|
